Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Roberto Cacciani"'
Autor:
Angela Battistini, Filippo Ansaldi, Laura Sticchi, Rocco Iudici, Paolo Durando, D Bellina, Chiara Paganino, Monica Zacconi, Anna Maria Di Bella, Cristiano Alicino, Alessandra Morando, Roberto Cacciani, Ilaria Barberis, A Talamini
Publikováno v:
Human Vaccines & Immunotherapeutics. 11:95-100
Influenza vaccination is a fundamental tool for the prevention of influenza in healthcare settings and its administration to healthcare workers (HCWs) is recommended in more than 40 countries including United States of America and many countries of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86eecd966c654e16613ef804e44d5a2c
https://doi.org/10.4161/hv.34362
https://doi.org/10.4161/hv.34362
Autor:
Paolo Durando, Roberto Rosselli, Ilaria Cremonesi, Andrea Orsi, Erika Albanese, Ilaria Barberis, Chiara Paganino, Cecilia Trucchi, Mariano Martini, Lorenzo Marensi, Valter Turello, the Ligurian Pneumococcal Study Group, Alessandro Bregante, Roberto Cacciani, Rocco Iudici, Diego La Marca, Leonardo Pedano, Amadio Franco Petrucci, Maria Santolini, Valentina Sbisà, Monica Zacconi
Publikováno v:
Human Vaccines & Immunotherapeutics. 11:172-177
BackgroundIn September 2011 the European Medical Agency authorized the use of 13-valent pneumococcal conjugate vaccine (PCV13) in adults aged ≥50 years. The same occurred in the US in December 2011 when the Food and Drug Administration approved the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c834dfa378db22d5c14d43d6e593ff2d
https://doi.org/10.4161/hv.34420
https://doi.org/10.4161/hv.34420
Autor:
Cristiano, Alicino, Rocco, Iudici, Ilaria, Barberis, Chiara, Paganino, Roberto, Cacciani, Monica, Zacconi, Angela, Battistini, Dorotea, Bellina, Anna Maria, Di Bella, Antonella, Talamini, Laura, Sticchi, Alessandra, Morando, Filippo, Ansaldi, Paolo, Durando
Influenza vaccination is a fundamental tool for the prevention of influenza in healthcare settings and its administration to healthcare workers (HCWs) is recommended in more than 40 countries including United States of America and many countries of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ec0bcffaeb18c5dd3ba2b65fc3fbd9f5
http://hdl.handle.net/11567/893421
http://hdl.handle.net/11567/893421
Autor:
Paolo, Durando, Roberto, Rosselli, Ilaria, Cremonesi, Andrea, Orsi, Erika, Albanese, Ilaria, Barberis, Chiara, Paganino, Cecilia, Trucchi, Mariano, Martini, Lorenzo, Marensi, Valter, Turello, The Ligurian Pneumococcal, Study Group, Alessandro, Bregante, Roberto, Cacciani, Rocco, Iudici, Diego, La Marca, Leonardo, Pedano, Amadio Franco, Petrucci, Maria, Santolini, Valentina, Sbisà, Monica, Zacconi
Publikováno v:
Human vaccinesimmunotherapeutics. 11(1)
In September 2011 the European Medical Agency authorized the use of 13-valent pneumococcal conjugate vaccine (PCV13) in adults aged ≥50 years. The same occurred in the US in December 2011 when the Food and Drug Administration approved the use of PC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a67bca6210bcd8385960f04c2977b124
https://pubmed.ncbi.nlm.nih.gov/25483531
https://pubmed.ncbi.nlm.nih.gov/25483531
Autor:
Mario Roberto Sertoli, Marimo Sato-Matsushita, Roberto Cacciani, Paolo Durando, Andrea De Maria, Rocco Iudici, Michele Sommariva, Valeria De Giorgi, Enrico Balleari, Ena Wang, Omar Racchi, Antonio Di Meglio, Francesco M. Marincola, Maria Libera Ascierto, Carlotta Massucco, Nicoletta Provinciali, Manlio Ferrarini, Davide Bedognetti, Elena Gugiatti, Simonetta Zupo, Cristiano Alicino, Chiara Dellepiane, Filippo Ansaldi
Publikováno v:
Journal for Immunotherapy of Cancer
We previously showed that long-lasting complete remission (CR) non-Hodgkin lymphoma (NHL) patients treated with rituximab-containing chemotherapy have an attenuated antibody response to virosomal (Bedognetti et al, J. Immunology, 2011) or MF-59 adjuv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97f7edd919fe91660caa4fe1da5c6a39
https://doi.org/10.1186/2051-1426-1-s1-p197
https://doi.org/10.1186/2051-1426-1-s1-p197
Publikováno v:
Human vaccinesimmunotherapeutics. 9(3)
HBV surface antigen (HBsAg) variants may impair diagnosis or allow the virus to escape vaccine-induced immunity and their circulation in the population can represent a Public Health threat. Their prevalence, however, is not yet completely established
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1a809587dda2b7c5320edbee68892e9
https://pubmed.ncbi.nlm.nih.gov/23296324
https://pubmed.ncbi.nlm.nih.gov/23296324